Skip to main content
Premium Trial:

Request an Annual Quote

Twist Bioscience: Patrick Finn

Patrick Finn has been promoted from senior VP of commercial operations to chief operating officer of Twist Bioscience, a new position at the company. Prior to joining Twist in 2015, Finn was VP of sales at Enzymatics, and before that, he held various positions at Agilent Technologies, Beckman Coulter, Invitrogen, and GE Healthcare/Amersham International. He holds a PhD in nucleic acid chemistry from the University of Southampton in England and a BSc in chemistry from Heriot-Watt University in Scotland.

The Scan

NFTs for Genome Sharing

Nature News writes that non-fungible tokens could be a way for people to profit from sharing genomic data.

Wastewater Warning System

Time magazine writes that cities and college campuses are monitoring sewage for SARS-CoV-2, an approach officials hope lasts beyond COVID-19.

Networks to Boost Surveillance

Scientific American writes that new organizations and networks aim to improve the ability of developing countries to conduct SARS-CoV-2 genomic surveillance.

Genome Biology Papers on Gastric Cancer Epimutations, BUTTERFLY, GUNC Tool

In Genome Biology this week: recurrent epigenetic mutations in gastric cancer, correction tool for unique molecular identifier-based assays, and more.